Updated: Apr 30, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Chunxia Chen1, Yuequan Shi1, Wenting Cao1
1Department of Radiology, Fujian Maternity and Child Health Hospital & Fujian Key Laboratory of Women and Children's Critical Diseases Research, 350001 Fuzhou, Fujian, China.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Genetic programming (GP) effectively classifies early-stage endometrial cancer (EC) using limited MRI data. This approach automatically extracts key features for accurate FIGO stage IA/IB differentiation, aiding clinical decisions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: